The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings

RW Paterson, RL Brown, L Benjamin, R Nortley… - Brain, 2020 - academic.oup.com
Preliminary clinical data indicate that severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection is associated with neurological and neuropsychiatric illness …

Clinical characteristics and outcome of patients diagnosed with psychogenic nonepileptic seizures: a 5-year review

SS O'Sullivan, JE Spillane, EM McMahon… - Epilepsy & behavior, 2007 - Elsevier
OBJECTIVE: The goal of this article was to describe the clinical characteristics and
outcomes of patients diagnosed with psychogenic nonepileptic seizures (PNES) …

Myasthenia and related disorders of the neuromuscular junction

J Spillane, DJ Beeson, DM Kullmann - Journal of Neurology …, 2010 - jnnp.bmj.com
Our understanding of transmission at the neuromuscular junction has increased greatly in
recent years. We now recognise a wide variety of autoimmune and genetic diseases that …

Thromboembolic risk with IVIg: incidence and risk factors in patients with inflammatory neuropathy

M Kapoor, J Spillane, C Englezou, S Sarri-Gonzalez… - Neurology, 2020 - AAN Enterprises
Our objective was to evaluate whether IV immunoglobulin (IVIg) increases the risk of
thromboembolic events in neurology outpatients with inflammatory neuropathies, as there is …

IVIg-exposure and thromboembolic event risk: findings from the UK Biobank

M Kapoor, I Hunt, J Spillane, LJ Bonnett… - Journal of Neurology …, 2022 - jnnp.bmj.com
Background Arterial and venous thromboembolic events (TEEs) have been associated with
intravenous Ig use, but the risk has been poorly quantified. We aimed to calculate the risk of …

Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies

S Rajakulendran, S Viegas, J Spillane, RS Howard - Journal of neurology, 2012 - Springer
A humoral basis for myasthenia gravis was established in the 1970s following the
identification of pathogenic antibodies directed against the post-synaptic acetylcholine …

[BOOK][B] The molecular and clinical pathology of neurodegenerative disease

PA Lewis, JE Spillane - 2018 - books.google.com
The Molecular and Clinical Pathology of Neurodegenerative Disease brings together in one
volume our current understanding of the molecular basis of neurodegeneration in humans …

Spectrum of clinical features in X-linked myotubular myopathy carriers: an international questionnaire study

SFI Reumers, F Braun, JE Spillane, J Böhm… - Neurology, 2021 - AAN Enterprises
Objective To characterize the spectrum of clinical features in a cohort of X-linked myotubular
myopathy (XL-MTM) carriers, including prevalence, genetic features, clinical symptoms, and …

[HTML][HTML] Signal, bias, and the role of transcriptome assembly quality in phylogenomic inference

JL Spillane, TM LaPolice, MD MacManes… - BMC ecology and …, 2021 - Springer
Background Phylogenomic approaches have great power to reconstruct evolutionary
histories, however they rely on multi-step processes in which each stage has the potential to …

Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol

S Finlayson, J Spillane, DM Kullmann… - Muscle & …, 2013 - Wiley Online Library
Introduction: Slow channel congenital myasthenic syndrome is a dominant disorder
characterized by prolonged acetylcholine receptor ion‐channel activation. Methods …